Zurueck zur Suche

Reporte zur Charge U009260

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

14Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MD 7 OH 4 VA 2 MI 1

VAERS 2565737

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U009260

gering
Staat
MI
Alter
5,0
Geschlecht
F
Eingang
23.01.2023
Impfdatum
20.01.2023
Beginn
20.01.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Dermatitis Erythema Skin warm

Symptomtext

Mom contacted and informed her child should be given another MMRV vaccine in 4 weeks.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dermatitis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
Mom reported the last set of shots child had been given caused a very large, red, raised, and warm to the touch area on her arm. Mom was unsure what specific vaccine caused the reaction, and agreed to have child receive the MMRV vaccine on 1/20/2023.
Vorherige Impfungen
-

VAERS 2483553

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U009260

gering
Staat
OH
Alter
6,0
Geschlecht
F
Eingang
20.10.2022
Impfdatum
20.09.2022
Beginn
20.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AEs; administration of expired PROQUAD vaccine to 2 patients; This spontaneous report was received from a registered nurse and refers to a 6-year-old female patient. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On 29-SEP-2022, the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, at a dose of 0.5ml, lot number: U009260, which was determined to be valid lot number for measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD), with an expiration date reported as: 19-SEP-2022 (route of administration, and anatomical site of injection were not reported) as prophylaxis (expired product administered). No additional adverse event was reported. This is one of two reports from the same reporter.; Sender's Comments: US-009507513-2209USA009292:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2466391

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U009260

gering
Staat
OH
Alter
-
Geschlecht
M
Eingang
01.10.2022
Impfdatum
20.09.2022
Beginn
20.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AEs; administration of expired PROQUAD vaccine to 2 patients on 9/20/22.; This spontaneous report has been received from a nurse concerning a 6-year-old male patient. The patient's concurrent conditions, medical history, concomitant therapies and drug/allergy history were not reported. On 20-SEP-2022, the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD), 0.5 milliliter (ml) (lot # U009260, has been verified to be a valid lot number for measles, mumps, rubella and varicella [oka-merck] virus vaccine live [rHA] [PROQUAD], expiration date reported and upon internal validation established as 19-SEP-2022) (anatomical location and route of administration were not provided) for prophylaxis (Expired product administered). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2462029

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U009260

gering
Staat
OH
Alter
6,0
Geschlecht
F
Eingang
27.09.2022
Impfdatum
20.09.2022
Beginn
20.09.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine adminstered 10 hours after expiration date

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2462022

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U009260

gering
Staat
OH
Alter
6,0
Geschlecht
M
Eingang
27.09.2022
Impfdatum
20.09.2022
Beginn
20.09.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine was expired by 10 hours time when administered

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 1838625

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U009260

gering
Staat
VA
Alter
1,0
Geschlecht
U
Eingang
03.11.2021
Impfdatum
28.10.2021
Beginn
28.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration Wrong product administered

Symptomtext

the patient received PROQAD and VARlV AX, the patient was supposed to get MMRII and V ARlVAX.; the patient received PROQAD and VARlV AX, the patient was supposed to get MMRII and V ARlVAX.; This spontaneous report was received from a Licensed Practical Nurse (LPN) and refers to a 12 month old patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 28-OCT-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # U009260 with expiration date of 19-SEP-2022) and with varicella virus vaccine live (oka/merck) (VARIVAX) (lot # T024285 with expiration date of 15-JUL-2022) for prophylaxis (doses, routes of administration, and anatomical location were not reported). The reporter stated that the patient was supposed to get Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (MMRII) and varicella virus vaccine live (oka/merck) (VARIVAX) (inappropriate schedule of product administration and wrong product administered). No other issues or concerns were noted. No product quality complaint (PQC) was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1706379

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U009260

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
17.09.2021
Impfdatum
20.08.2021
Beginn
20.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; incorrect product storage; This spontaneous report has been received from an office manager referring to an unknown age and gender patient. The patient's concomitant medications, pertinent medical history, drug reactions or allergies were not reported. On 20-AUG-2021, the patient was vaccinated with the improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (dose, strength, route of administration and anatomical location were not provided; lot # U009260, expiration date reported as 19-SEP-2022, albumin status recombinant Human albumin (rHA)) for prophylaxis. The vaccine underwent temperature excursion of -10.7 degree Celsius for total 192 hours. It was reported that there were no previous temperature excursions. At the time of report, there was no adverse event (AE) reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1706378

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U009260

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
17.09.2021
Impfdatum
18.08.2021
Beginn
18.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; incorrect product storage; This spontaneous report has been received from an office manager referring to an unknown age and gender patient. The patient's concomitant medications, pertinent medical history, drug reactions or allergies were not reported. On 18-AUG-2021, the patient was vaccinated with the improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (dose, strength, route of administration and anatomical location were not provided; lot # U009260, expiration date reported as 19-SEP-2022, albumin status recombinant Human albumin (rHA)) for prophylaxis. The vaccine underwent temperature excursion of -10.7 degree Celsius for total 192 hours. It was reported that there were no previous temperature excursions. At the time of report, there was no adverse event (AE) reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1706377

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U009260

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
17.09.2021
Impfdatum
25.08.2021
Beginn
25.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; incorrect product storage, -10.7 degrees Celsius, 192 hours; This spontaneous report has been received from an office manager referring to an unknown age and gender patient. The patient's concomitant medications, pertinent medical history, drug reactions or allergies were not reported. On 25-AUG-2021, the patient was vaccinated with the improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (dose, strength, route of administration and anatomical location were not provided; lot # U009260, expiration date reported as 19-SEP-2022, albumin status recombinant Human albumin (rHA)) for prophylaxis. The vaccine underwent temperature excursion of -10.7 degree Celsius for total 192 hours. It was reported that there were no previous temperature excursions. At the time of report, there was no adverse event (AE) reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1691113

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U009260

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
11.09.2021
Impfdatum
23.08.2021
Beginn
23.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; PROQUAD was administered on 08/23/2021 following a temperature excursion; This spontaneous report as received from an office manager refers to a patient of unknown age and gender. Pertinent medical history, drug reactions, allergies and concomitant medications were not reported. On 23-AUG-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) (lot number: U009260, expiration date: 19-SEP-2022; dose and route of administration not provided). The vaccine was stored in temperature -10.7 degrees Celsius for 192 hours 0 minutes and 0 seconds. There was no previous temperature excursion. No adverse event was reported. This is one of the four cases from the same reporter.; Sender's Comments: US-009507513-2108USA007463: US-009507513-2108USA007542: US-009507513-2109USA002267:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1691112

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U009260

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
11.09.2021
Impfdatum
23.08.2021
Beginn
23.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE reported; administered following temperature excursion; This spontaneous report was received from an office manager and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, previous drug reactions or allergies were not reported. On 23-AUG-2021, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), rHA, lot # U009260 (lot # was determined as valid), expiration date was provided and also validated as 19-SEP-2022 (dose, strength, route of administration and anatomical location were not provided) for prophylaxis (improper storage of product in use). It was stated, that the vaccine before administration was stored at the temperature of -10.7 Celsius degree (C) for 192 hours. It was not provided, if data logger was involved. No additional adverse event (AE) reported (no adverse event). The reporter provided permission to follow-up regarding the report. This is one of the two linked reports received from the same reporter.; Sender's Comments: US-009507513-2108USA007542:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1661992

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U009260

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
01.09.2021
Impfdatum
25.08.2021
Beginn
25.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; PROQUAD was administered on 08/25/2021 following a temperature excursion; This spontaneous report has been received from an office manager referring to an unknown age and gender patient. The patient's concomitant medications, pertinent medical history, drug reactions or allergies were not reported. On 25-AUG-2021, the patient was vaccinated with the improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (albumin status recombinant Human albumin (rHA)) (PROQUAD) (dose, strength, route of administration and anatomical location were not provided; lot # U009260, expiration date reported as 19-SEP-2022) for prophylaxis (product storage error). The vaccine underwent temperature excursion of -10.7 degree Celsius for total 192 hours. It was reported that there were no previous temperature excursions. At the time of report, there was no additional adverse event (AE).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1660900

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U009260

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
01.09.2021
Impfdatum
24.08.2021
Beginn
24.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported.; PROQUAD was administered on 08/24/2021 following a temperature excursion.; This spontaneous report was received from an office manager and refers to a patient of unspecified age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, past drug reactions or allergies. On 24-AUG-2021, the patient was vaccinated with an improperly stored Measles, Mumps, Rubella, and Varicella (Oka-Merck) Virus Vaccine Live recombinant human albumin (rHA) (PROQUAD) (concentration, dose, vaccination scheme frequency, route, and anatomical site of administration were not reported; lot number U009260 was verified to be a valid lot number with an expiration date reported and established as 19-SEP-2022) for prophylaxis. It was reported that the administered vaccine experienced a temperature excursion of minus (-)10.7 degrees Celsius (?C) for a time frame of192 hours (product storage error). If there was any previous temperature excursion this information was not reported. No additional adverse event was provided. This is one of two reports reported by the same reporter. Sender's Comments: US-009507513-2108USA007542.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1634782

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U009260

gering
Staat
VA
Alter
-
Geschlecht
U
Eingang
26.08.2021
Impfdatum
20.08.2021
Beginn
20.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No signs or symptoms reported. No other AE or PQC reported.; Medical assistant called to report a temperature excursion. PROQUAD (lot/exp. U009260 9/19/2022) was administered to one patient after the excursion occurred.; This spontaneous report was received from a medical assistant referring to a patient of unspecified age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, past drug reactions or allergies. On 20-AUG-2020, the patient was vaccinated with one (1) time dose Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live recombinant human albumin (rHA) (PROQUAD) (dose number, vaccination scheme frequency, route and anatomical site of administration were not provided; lot number U009260 was verified to be a valid lot number with an expiration date reported and established as 19-SEP-2022) for prophylaxis. It was reported that the administered vaccine had experienced a temperature excursion of 4.6 degrees Celsius (C) with a time frame of 3 hour and 57 minutes (product storage error). No data logger was reported. No previous temperature excursion was reported. No signs or symptoms were reported. No additional adverse event (AE) was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-